glp-1 without diabetes Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Diabetes: A Systematic Review and Meta-Analysis A Comprehensive Review of the

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist, which means it mimics a naturally occurring hormone that helps regulate both blood sugar and appetite

The net benefit of GLP-1 receptor agonists in adults with overweight or obesity who do not have diabetes depends on their weight loss target and willingness to accept harms, according to researchers

Glucagon-like peptide-1 is specifically involved in sweet taste transmission

This is a reason why GLP-1 medications work best within a broader health program that includes nutrition guidance and physical activity rather than as a standalone intervention

Nausea is the most common GI side effect and often occurs in the morning or after longer periods without eating